LONDON: The United Kingdom has become the first country in Europe to approve a new once-daily pill to help people lose weight and manage Type 2 diabetes. It can additionally be used to improve blood sugar control in adults with Type 2 diabetes that is not adequately controlled. Unlike injectable GLP-1 treatments, orforglipron is taken as a tablet once a day and can be taken at any time. Experts said a once-daily GLP-1 tablet could provide a more convenient option for people seeking weight-loss treatment who prefer oral medication over injections. The findings showed that some patients experienced a significant reduction in depression symptoms, with around four in 10 participants reaching a level considered remission.